C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
12/2001
12/13/2001	WO2001094333A2 Process for the preparation of benzoyl substituted bicyclic compounds and chiral benzopyran derivatives
12/13/2001	WO2001094331A2 Methods for producing amino-substituted chromanes
12/13/2001	WO2001094330A2 Methods for producing amino substituted chromanes
12/13/2001	WO2001093690A2 An improved method for extracting cocoa procyanidins
12/13/2001	WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters
12/13/2001	WO2001036424A3 Naphthopyrans having a perfluoroalkyl substituent in position 5, preparation and compositions and matrices containing them
12/13/2001	CA2700312A1 An improved method for extracting cocoa procyanidins
12/12/2001	EP1161434A1 Pyridopyranoazepine derivatives, preparation and therapeutic use
12/12/2001	EP1161231A2 Method of inhibiting a chaperone protein
12/12/2001	EP0900230B1 Esculetin derivatives
12/12/2001	CN1326450A Hydroxyflavone derivatives as tau protein kinase inhibitors
12/12/2001	CN1325686A Flavonoids used as anti-rejection agent
12/11/2001	US6329535 Reacting ketoisophorone (kip) with an acylating agent in the presence of a proton acid to give a solution of trimethylhydroquinone ester which is reacted with allyl alcohol derivative in presence of zinc halides and acids
12/11/2001	US6329534 Useful for therapy of type ii diabetes, obesity, hyperglycemia, inadequate glucose clearance, hyperinsulinemia, hypertriglyceridemia, and high-circulating glucocorticoid levels
12/11/2001	US6329394 Medical use for tachykinin antagonists
12/11/2001	US6329377 Enzyme inhibitors for nervous system disorders
12/11/2001	US6329189 Enzyme producing tartaric acid ether compound and process for producing tartaric acid ether compounds using this enzyme
12/08/2001	CA2349776A1 Novel crystalline forms of (3s-trans)-2-¬3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2h-1-benzopyran-7-yl\|-4-(trifluoromethyl)-benzoic acid
12/06/2001	WO2001092563A2 Method for detecting a detectable product
12/06/2001	WO2001092250A2 Synthesis of 2-acyl substituted chromanes and intermediates thereof
12/06/2001	WO2001092249A2 Chiral and achiral synthesis of 2-acyl substituted chromanes and their derivatives
12/06/2001	WO2001049673A3 Compounds and methods for modulation of estrogen receptors
12/06/2001	WO2001007021A3 Process for the improvement of spermatozoa fertilization activity
12/06/2001	US20010049354 Protecting solid-state proteins from the effects of ionizing radiation
12/06/2001	CA2411315A1 Method for detecting a detectable product
12/05/2001	EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors
12/05/2001	EP1159254A1 Oxyalkylene-substituted aminophenol intermediate
12/05/2001	EP1017690B1 Novel aromatic substituted naphthopyrans
12/05/2001	EP0814754B1 Reduction of hair growth
12/05/2001	EP0693065B1 Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
12/05/2001	CN1325452A Method for the preparation of quercetin and isoquercetin derivatives
12/05/2001	CN1325393A Method for producing luteolin and luteolin derivatives
12/05/2001	CN1325303A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses
12/04/2001	US6326153 Polynucleotide sequencing
11/2001
11/29/2001	WO2001090098A1 Koumarin derivative and use thereof
11/29/2001	US20010046963 Inhibiting cyclooxygenase-2 biosynthesis and Nuclear factor kappa B synthesis; treatment of arthritis and Alzheimer's disease; administering in food
11/28/2001	EP1157984A2 Trypsin substrate and diagnostic device, and method of using same
11/28/2001	EP1156815A2 Process for extracting polyphenolic antioxidants from purine-containing plants
11/28/2001	CN1323534A Continuous technolgical process of extracting soybean and separating protein, isoflavone, oligosaccharide and saponin
11/27/2001	US6323238 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
11/27/2001	US6323212 Method for reducing pain, which comprises administering an effective analgesic amount of the morphinan derivative
11/27/2001	US6323018 Used in therapy
11/22/2001	WO2001087873A1 Process for preparing cis-aminochromanols
11/22/2001	WO2001087872A1 Methods for producing amino substituted chromanes and intermediates therefor
11/22/2001	WO2001087871A2 Methods for producing amino substituted chromanes and intermediates therefor
11/22/2001	WO2001087830A2 Substituted thioacetamides
11/22/2001	WO2001087297A1 Cannabinoid drugs
11/22/2001	WO2001087296A1 Methods for decreasing cell proliferation based on (3r, 4r)δ8-tetrahydrocannabinol-11-oic acids
11/22/2001	WO2001087295A1 Methods for decreasing cell proliferation based on (3r, 4r)-δ8-tetrahydrocannabinol-11-oic acids
11/22/2001	WO2001034116A3 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias
11/22/2001	US20010044548 Combining vitamin E containing mixture with adsorbent effecting adsorption of isomers, then selectively desorbing with solvent under supercritical conditions; ester interchange; esterification
11/22/2001	US20010044434 Treating timidity and enhancing libido in postmenopausal women, or treating male sexual dysfunction by administering to a patient in need thereof an effective amount of an estrogen agonist/antagonist
11/22/2001	US20010043976 Solvent extraction of ginkgo biloba leaves including a deterpenation step using an aliphatic ester solvent.
11/22/2001	CA2409116A1 Substituted thioacetamides
11/22/2001	CA2409005A1 Methods for decreasing cell proliferation based on (3r, 4r)-.delta.8-tetrahydrocannabinol-11-oic acids
11/22/2001	CA2408961A1 Use of ajulemic acid and related cannabinoids for the treatment of cancer
11/21/2001	EP1155021A1 Hesperitin pro-forms with enhanced bioavailability
11/21/2001	EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001	EP0909267B1 Novel 1,3-diphenylpropane derivatives having inhibitory activity against tyrosinase and process for preparation thereof
11/21/2001	EP0906326B1 Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine
11/21/2001	CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001	CN1323291A Diaminopropionic acid derivatives
11/21/2001	CN1322724A Isoflavane compound in spherophys and its medicine application
11/21/2001	CN1322723A Method of extracting flavone and terpenes from gingko leaf with CO2 in subcritical state
11/21/2001	CN1322722A Preparation of escoparone contrast product
11/21/2001	CN1075068C Coumarin derivatives, producing process thereof and their use as intermediates
11/20/2001	US6320074 In vivo modulation of lipid metabolism, skin-related processes, autoimmune diseases, fatty acid metabolism, malignant cell development, premalignant lesions, or programmed cell death
11/20/2001	US6319930 Substituted dimeric compounds
11/20/2001	US6319929 Suksdorfin analogs, compositions thereof, and methods for making and using thereof
11/20/2001	US6319428 Perfluorinated amide salts and their uses as ionic conducting materials
11/15/2001	US20010041802 Glucocorticoid receptor antagonists for treatment of diabetes
11/15/2001	US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001	US20010041718 Cis-6-(4-fluoro-phenyl)-5-(4-(2-piperidin-1-yl-ethoxy)-phenyl) -5,6,7,8-tetrahydronaphthalene-2-ol, for example, and other estrogen agonists/antagonists to treat rheumatoid arthritis, colon cancer, wounds, cataracts and skin wrinkles
11/15/2001	US20010041163 Xanthene dye structure with a hydrophilic and lipophilic group bound to the same carbon, ultrasonic
11/15/2001	CA2334827A1 Trypsin substrate and diagnostic device, and method of using same
11/14/2001	EP1153604A1 Adp-ribosylation inhibitors and remedies for endotoxic bacterial enteric infection containing proanthocyanidin as the active ingredient
11/14/2001	EP1153021A1 Naphthopyrans and phenanthropyrans annelated in c5-c6 with a bicyclic group, and compositions and (co)polymer matrices containing them
11/14/2001	EP1153020A1 Production of isoflavone derivatives
11/14/2001	EP1153019A1 Photoactive propane derivatives and orientation layers
11/14/2001	EP0712399B1 Recovery of tocopherols
11/14/2001	CN1322209A Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor
11/14/2001	CN1322200A Enantioselective synthesis
11/14/2001	CN1322132A Bioflavonoid as blood gloucose level lowering agent
11/14/2001	CN1321640A Method for separating and recovery of protein and isoflavone from plant raw material
11/14/2001	CN1321444A Composition contg. anthocyanidin
11/13/2001	US6316494 For therapy and prophylaxis of bone loss, osteoporosis, cardiovascular diseases, cognitive disorders, menopausal symptoms, incontinence, obesity, dysmenorrhea, dysfunctional uterine bleeding, acne, hirsutism, post-partum lactation
11/13/2001	US6316486 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/13/2001	US6316404 Treatment of non-insulin-dependent diabetes mellitus using an rxr agonist alone or in combination with a ppar.gamma. agonist such as a thiazolidinedione compound.
11/13/2001	US6315928 For ophthalmic lenses
11/13/2001	CA2064793C Hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same
11/08/2001	WO2001083511A1 Method of searching for arteriosclerosis inhibitors and shrinkers
11/08/2001	WO2001083469A1 Cdk inhibitors having 3-hydroxychromen-4-one structure
11/08/2001	WO2001083438A2 New gamma selective retinoids
11/08/2001	WO2001083427A1 PPARη MODULATORS
11/08/2001	WO2001082888A1 Lipochroman-6 as no-synthase inhibitor and uses
11/08/2001	WO2001041760A3 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/08/2001	WO2001032644A3 Excitatory amino acid derivatives
11/08/2001	WO2001023352A3 Preparation of sulfonyl imine compounds
11/08/2001	US20010039356 Photochromic; ophthalmic or solar article; polymeric matrices
11/08/2001	US20010039021 Polyketides

1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 242